Skip to main content
logo
Amgen Inc. (LON:0R0T)
London flag London · Delayed Price · Currency is GBP · Price in USD
370.67
-5.47 (-1.45%)
At close: Mar 12, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Prolia Revenue
4.41B4.37B
Prolia Revenue Growth
0.91%8.05%
ENBREL Revenue
2.23B3.32B
ENBREL Revenue Growth
-32.87%-10.31%
XGEVA Revenue
2.08B2.23B
XGEVA Revenue Growth
-6.34%5.35%
Repatha Revenue
3.02B2.22B
Repatha Revenue Growth
35.73%35.90%
Otezla Revenue
2.27B2.13B
Otezla Revenue Growth
6.54%-2.83%
TEPEZZA Revenue
1.90B1.85B
TEPEZZA Revenue Growth
2.81%313.17%
EVENITY Revenue
2.10B1.56B
EVENITY Revenue Growth
34.36%34.74%
KYPROLIS Revenue
1.41B1.50B
KYPROLIS Revenue Growth
-6.05%7.13%
Nplate Revenue
1.52B1.46B
Nplate Revenue Growth
4.67%-1.42%
Aranesp Revenue
1.39B1.34B
Aranesp Revenue Growth
3.50%-1.47%
BLINCYTO Revenue
1.56B1.22B
BLINCYTO Revenue Growth
28.21%41.23%
KRYSTEXXA Revenue
1.34B1.19B
KRYSTEXXA Revenue Growth
13.08%335.66%
Vectibix Revenue
1.18B1.05B
Vectibix Revenue Growth
12.44%6.20%
TEZSPIRE Revenue
1.48B972.00M
TEZSPIRE Revenue Growth
52.06%71.43%
Other Products Revenue
7.26B5.63B
Other Products Revenue Growth
29.00%19.89%
Product Revenue
35.15B32.03B
Product Revenue Growth
9.75%19.01%
Other Revenue
1.60B1.40B
Other Revenue Growth
14.66%9.22%
Revenue (Total)
36.75B33.42B
Revenue (Total) Growth
9.95%18.57%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
U.S. Revenue
26.42B23.86B
U.S. Revenue Growth
10.71%20.48%
Rest of World (ROW) Revenue
10.33B9.56B
Rest of World (ROW) Revenue Growth
8.06%14.04%
Revenue (Total)
36.75B33.42B
Revenue (Total) Growth
9.95%18.57%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
McKesson Corporation Revenue
26.25B22.17B
McKesson Corporation Revenue Growth
18.40%16.48%
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue
20.99B18.39B
Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue Growth
14.13%10.60%
Cardinal Health, Inc. Revenue
12.56B11.28B
Cardinal Health, Inc. Revenue Growth
11.39%15.38%
Updated Dec 31, 2025. Data Source: Fiscal.ai.